| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0075 | 1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |